Scenarios on costs and savings of influenza treatment and prevention for Dutch healthy working adults.

Objective: To assess the economic implications of strategies for influenza control among healthy working adults in The Netherlands.

Methods: The economic evaluation was based on a pharmaco-economic model from the societal perspective. This model involves the direct and indirect costs of vaccination or treatment and the direct and indirect savings (averted costs) due to the control strategy.

Pharmacoeconomics of influenza vaccination for healthy working adults: reviewing the available evidence.

A favourable pharmacoeconomic profile has been well established for influenza vaccination in the elderly. For employers relevant benefits seem to exist for vaccinating healthy working adults to avert absenteeism and related production losses. From a pharmacoeconomic point of view it is relevant to consider whether societal benefits of vaccination for healthy working adults is worthwhile given the costs of vaccination for the community.